Kidney Disease
163
17-32 of 148
Gianluigi Savarese, MD
Carolyn S. P. Lam, MBBS, PhD
Jürgen Floege, MD
Muthiah Vaduganathan, MD
Carolyn S. P. Lam, MBBS, PhD
Muthiah Vaduganathan, MD, MPH
Jurgen Floege MD
John McMurray, MD
Hiddo L. Heerspink, PhD
John McMurray, MD
Pardeep Jhund, MD, PhD
John McMurray, MD
Hiddo L. Heerspink, PhD
Pardeep Jhund, MD, PhD
John McMurray, MD
Muthiah Vaduganathan, MD
Anne Langsted, MD, PhD
- ACC.24
Increasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
Alexander J. Blood, MD
George L. Bakris, MD
David Bushinsky, MD
Lars Lund, MD
Carolyn Lam, MD, PhD
Maria Luiza Caramori, MD, PhD
Ana Maria Cebrián-Cuenca, MD, PhD
Pam R. Taub, MD, FACC, FASPC
- Kidney DiseaseA multidisciplinary approach to managing potassium levels in patients with HF when optimizing RAASi therapy
Antoni Bayés-Genís, MD, PhD
Patrick Rossignol, MD, PhD
Ellie Kelepouris, MD
Stephen J. Greene, MD
